<?xml version='1.0' encoding='utf-8'?>
<document id="32285742"><sentence text="In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes."><entity charOffset="31-47" id="DDI-PubMed.32285742.s1.e0" text="ganoderic acid A" /></sentence><sentence text="Context: Ganoderic acid A (GAA) is usually used to prevent cancers or other diseases, which make it likely to be used with other drugs metabolized by cytochromes P450"><entity charOffset="9-25" id="DDI-PubMed.32285742.s2.e0" text="Ganoderic acid A" /><entity charOffset="27-30" id="DDI-PubMed.32285742.s2.e1" text="GAA" /><pair ddi="false" e1="DDI-PubMed.32285742.s2.e0" e2="DDI-PubMed.32285742.s2.e0" /><pair ddi="false" e1="DDI-PubMed.32285742.s2.e0" e2="DDI-PubMed.32285742.s2.e1" /></sentence><sentence text="Objective: This study investigates the effect of GAA on eight major cytochrome P450 isoforms in human liver microsomes"><entity charOffset="49-51" id="DDI-PubMed.32285742.s3.e0" text="GAA" /></sentence><sentence text="Material and method: The effects of GAA (100 μM) on eight human liver CYP isoforms (i"><entity charOffset="36-38" id="DDI-PubMed.32285742.s4.e0" text="GAA" /></sentence><sentence text="e" /><sentence text=", 1A2, 3A4, 2A6, 2E1, 2D6, 2C9, 2C19, and 2C8) were investigated in vitro using human liver microsomes (HLMs) with specific substrates for the CYPs, and the enzyme kinetic parameters were calculated" /><sentence text="Results: The results showed that GAA inhibited the activity of CYP3A4, 2D6, and 2E1, but did not affect other isoforms"><entity charOffset="33-35" id="DDI-PubMed.32285742.s7.e0" text="GAA" /></sentence><sentence text=" The inhibition of CYP3A4, 2D6, and 2E1 was concentration-dependent with IC50 values of 15" /><sentence text="05, 21" /><sentence text="83, and 28" /><sentence text="35 μM, respectively" /><sentence text=" Additionally, GAA was not only a non-competitive inhibitor of CYP3A4, but also a competitive inhibitor of CYP2D6 and 2E1, with Ki values of 7"><entity charOffset="15-17" id="DDI-PubMed.32285742.s12.e0" text="GAA" /></sentence><sentence text="16, 10" /><sentence text="07, and 13" /><sentence text="45 μM" /><sentence text=" Meanwhile, the inhibition of CYP3A4 was time-dependent, with the KI/Kinact value of 7" /><sentence text="91/0" /><sentence text="048 μM/min" /><sentence text="Discussion and conclusion: The in vitro study indicated that GAA has the potential to result in drug-drug interactions with other drugs metabolized by CYP3A4, 2D6, and 2E1"><entity charOffset="61-63" id="DDI-PubMed.32285742.s19.e0" text="GAA" /></sentence><sentence text=" Further clinical studies are needed for the identification of this interaction" /><sentence text="" /></document>